Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It?

The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

This article was originally published here.